Who are Vitamin B12 (Cyanocobalamin)'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Methylcobalamin (methylB12), Vitamin B12.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/vitamin-b12-cyanocobalamin.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Vitamin B12 (Cyanocobalamin) — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vitamin B12 (Cyanocobalamin) (Vitamin B12 (Cyanocobalamin)) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin / Essential nutrient. Area: Hematology; Neurology; Nutritional deficiency.

marketed Vitamin / Essential nutrient Methionine synthase; methylmalonyl-CoA mutase Hematology; Neurology; Nutritional deficiency Small molecule Live · refreshed every 30 min

Target snapshot

Vitamin B12 (Cyanocobalamin) (Vitamin B12 (Cyanocobalamin)) — University of Aarhus. Vitamin B12 (cyanocobalamin) acts as a coenzyme essential for DNA synthesis, myelin formation, and cellular metabolism.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Vitamin B12 (Cyanocobalamin) TARGET	Vitamin B12 (Cyanocobalamin)	University of Aarhus	marketed	Vitamin / Essential nutrient	Methionine synthase; methylmalonyl-CoA mutase
Methylcobalamin (methylB12)	Methylcobalamin (methylB12)	Arkansas Children's Hospital Research Institute	marketed	Vitamin B12 supplement / Cobalamin	Methionine synthase; methylmalonyl-CoA mutase cofactor
Vitamin B12	Vitamin B12	Acrotech Biopharma Inc.	marketed	Vitamin / Essential nutrient	Methionine synthase, methylmalonyl-CoA mutase

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin / Essential nutrient class)

Acrotech Biopharma Inc. · 1 drug in this class
University of Aarhus · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Vitamin B12 (Cyanocobalamin) — Competitive Intelligence Brief. https://druglandscape.com/ci/vitamin-b12-cyanocobalamin. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab